Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS)

CNY 10.15

(-1.36%)

EBITDA Summary of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's latest annual EBITDA in 2023 was -57.84 Million CNY , down -112.74% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd's latest quarterly EBITDA in 2024 Q3 was 264.46 Million CNY , down -17.2% from previous quarter.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported an annual EBITDA of 1.36 Billion CNY in 2022, down -0.03% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported an annual EBITDA of 1.38 Billion CNY in 2021, up 25.82% from previous year.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a quarterly EBITDA of 264.46 Million CNY for 2024 Q3, down -17.2% from previous quarter.
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd reported a quarterly EBITDA of 228.1 Million CNY for 2024 Q1, up 121.88% from previous quarter.

Annual EBITDA Chart of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (2023 - 2013)

Historical Annual EBITDA of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (2023 - 2013)

Year EBITDA EBITDA Growth
2023 -57.84 Million CNY -112.74%
2022 1.36 Billion CNY -0.03%
2021 1.38 Billion CNY 25.82%
2020 1.05 Billion CNY 47.79%
2019 745.87 Million CNY 45.3%
2018 516.75 Million CNY 28.24%
2017 401.63 Million CNY 29.45%
2016 313.34 Million CNY 143.66%
2015 125.44 Million CNY 60.48%
2014 79.3 Million CNY -7.97%
2013 86.32 Million CNY 0.0%

Peer EBITDA Comparison of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

Name EBITDA EBITDA Difference
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY 121.025%
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 101.599%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY 114.765%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 107.797%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 102.684%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 102.96%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 105.952%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 36.288%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY 151.993%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 108.536%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 107.784%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY 267.913%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 112.075%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 107.854%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY 116.291%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 75.294%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY 131.018%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 109.404%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 103.812%
CanSino Biologics Inc. -1.64 Billion CNY 96.487%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 104.901%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 106.879%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY 147.507%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY 16130.915%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 105.647%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 105.091%
HPGC Renmintongtai Pharmaceutical Corporation 474.3 Million CNY 112.196%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 101.269%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY -1473.897%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 107.214%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 108.726%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY 121.783%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY 137.211%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 103.621%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY 127.581%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 101.154%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 102.606%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 103.611%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 100.896%
China National Medicines Corporation Ltd. 2.82 Billion CNY 102.047%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY 121.629%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY 130.86%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 101.411%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY 121.697%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 101.04%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY 118.654%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY 116.582%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY 429.065%
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 105.615%
Guobang Pharma Ltd. 1.04 Billion CNY 105.555%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 109.135%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 106.886%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY 119.807%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY 1890.952%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 105.277%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY 117.662%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 110.777%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY 151.735%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 110.225%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY 123.091%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 102.924%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY 129.603%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 105.926%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY 128.425%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY 122.258%